Ad
related to: TPST StockSee how Invesco QQQ ETF can fit into your portfolio. Access the Nasdaq's Largest 100 non-financial companies in a Single Investment.
- Mutual Funds
Diversify Your Portfolio With
Invesco Mutual Funds.
- Water Resources ETF
Learn More About INVESCO's Water
Resources ETF.
- Invesco Bulletshares 2027
Learn More About bullethares And
How INVESCO Can Help You.
- QQQ Top 10 Holdings
Read The Most Frequently Asked
Questions About Invesco holdings.
- View Holdings
Explore QQQ's Innovative
Companies.
- Collateral ETF
Achieve Lower Costs and Tax
Efficiency With Invesco ETFs
- Mutual Funds
Search results
A high-level overview of Tempest Therapeutics, Inc. (TPST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
View the latest Tempest Therapeutics Inc. (TPST) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Tempest Therapeutics shares head back to earth after 4,000% gain. Shares of microcap oncology company Tempest Therapeutics Inc. TPST, -55.06% dropped more than 50% Thursday as investors took a breath after the stock's roughly 40-fold gain on Wednesday. 8 months ago - Market Watch.
Tempest Announces Appointment of Christine Pellizzari to its Board of Directors. (GlobeNewswire) Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Complete Tempest Therapeutics Inc. stock information by Barron's. View real-time TPST stock price and news, along with industry-best analysis.
The latest Tempest Therapeutics stock prices, stock quotes, news, and TPST history to help you invest and trade smarter.
Ideas. TPST (Tempest Therapeutics | NASDAQ:TPST) Shares of Tempest Therapeutics (NASDAQ:TPST) closed nearly 4,000% higher Wednesday after the company released updated data from a Phase 1/2 study of its drug TPST-1120 in the first-line treatment of advanced or metastatic hepatocellular carcinoma, a type of liver cancer. The stock closed at $9.77 a.
Ad
related to: TPST StockSee how Invesco QQQ ETF can fit into your portfolio. Access the Nasdaq's Largest 100 non-financial companies in a Single Investment.
